Clinical Trials
All Clinical Trials - Page 37 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT03495102Phase 3Completed
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
Dulaglutide
- NCT03463252Phase 2/Phase 3Recruiting
Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC
Gonadorelin
- NCT04268927Phase 2Unknown
Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET
Gonadorelin
- NCT03482024Phase 1Completed
A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function
Tirzepatide
- NCT02473406Phase 4Completed
Thymosin Alpha 1 in the Prevention of Pancreatic Infection Following Acute Necrotizing Pancreatitis
Thymosin-Alpha-1
- NCT03486392Phase 2Completed
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants
Liraglutide
- NCT03463772N/AUnknown
IVM Versus Standard IVF in Infertile Patients Diagnosed With PCOS
Gonadorelin
- NCT03466567Phase 1Completed
A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy Subjects
Semaglutide
- NCT03386162Phase 2Terminated
SAFIR-PI3K A Phase II Randomized Maintenance Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy in PIK3CA Mutated Advanced Breast Cancer
Gonadorelin
- NCT03516110N/ACompleted
Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy
Gonadorelin
- NCT03347890Phase 4Completed
Reward Mechanisms in Obesity
Liraglutide
- NCT03439709Phase 3Unknown
Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma
Lanreotide
- NCT03444025Phase 2Unknown
Neoadjuvant Goserelin for Triple Negative Breast Cancer
Gonadorelin
- NCT03331289Phase 4Completed
Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria
Exenatide
- NCT03492580N/ACompleted
A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease
Liraglutide
- NCT03434119Phase 3Terminated
Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents
Lixisenatide
- NCT03174353Phase 2Completed
A Phase II Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula
Lanreotide
- NCT03419624Phase 3Terminated
The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients
Exenatide
- NCT03423199Phase 3Unknown
PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY
Gonadorelin
- NCT03226821Phase 4Terminated
Body Composition and Adipose Tissue in HIV
Tesamorelin
- NCT03768518N/AUnknown
GLP-1 Receptor Expression in CHI
Exenatide
- NCT03466216Phase 1Terminated
Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET
Octreotide
- NCT06611904N/AUnknown
The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and Albuminuria
Dulaglutide
- NCT03398941N/AUnknown
The Effect of Preoperative Long Period Octreotide Combined With Postoperative Short Period Octreotide on the Complications After Pancreatectomy. A Prospective, Multicenter Clinical Trial
Octreotide
- NCT03225209Phase 2Completed
Medically Reproducing Bariatric Surgery
Liraglutide
- NCT03287960Phase 3Completed
Setmelanotide for the Treatment of Leptin Receptor (LEPR) Deficiency Obesity
Setmelanotide
- NCT03511768Phase 1/Phase 2Unknown
A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms
Octreotide
- NCT03431844N/ACompleted
Humanin Isoforms in Cardiac Muscle and Blood Plasma and Major Complications After Cardiac Operation
Humanin
- NCT03466021Phase 4Completed
Effects of Liraglutide in Chronic Obstructive Pulmonary Disease
Liraglutide
- NCT03383068Phase 4Unknown
Research of Intensive Metabolic Intervention Before Pregnancy in PCOS
Exenatide
- NCT03377660N/ATerminated
Resection of the Esophagus and Subsequent Weight Loss
Octreotide
- NCT03336034N/ATerminated
Assessment of Responsiveness to Treatment by Experience Sampling Method
Linaclotide
- NCT04797338Phase 4Unknown
Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders
Gonadorelin
- NCT03553602Phase 1/Phase 2Terminated
HDR Brachytherapy, EBRT and STAD for the Treatment of Prostate Cancer
Gonadorelin
- NCT03447132Phase 3Completed
Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant
Gonadorelin
- NCT03350191Phase 1Completed
A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus Patients
Exenatide
- NCT03375463Phase 1Completed
A Study of Tirzepatide (LY3298176) in Healthy Participants
Tirzepatide
- NCT03307720N/AUnknown
Agonist Versus Classical HCG Trigger (Poor Responders, Normoresponders and High Responders)
Gonadorelin
- NCT03306498N/AUnknown
Plasma Free Amino Acids in Patients With Hepatic Encephalopathy
KPV
- NCT02981069Phase 4Completed
Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM
Exenatide
- NCT03158090N/ARecruiting
The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research
Octreotide
- NCT03374956Phase 3Completed
Individualized Obesity Pharmacotherapy
Liraglutide
- NCT03363906Phase 1Completed
A Study of Dulaglutide in Healthy Participants
Dulaglutide
- NCT04290429EARLY_Phase 1Completed
Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD Patients
Teduglutide
- NCT03353350Phase 3Completed
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Efpeglenatide
- NCT03400722Phase 4Unknown
Double Ovarian Stimulation as Accumulation Strategy for Older Infertile Patients With Suboptimal Ovarian Response
Gonadorelin
- NCT03336983Phase 2Completed
Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients
Gonadorelin
- NCT02972060Phase 2Active Not Recruiting
ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer
Gonadorelin
- NCT03421639Phase 4Unknown
Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis
Gonadorelin
- NCT04839237Phase 2Withdrawn
The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients
Liraglutide